We are monitoring the impact of COVID-19 on Asia Pacific Metabolomics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 3321
Share on
Share on

Asia Pacific Metabolomics Market Research Report - Segmented By Product, Indication, Application & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis, Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 3321
Pages: 175

APAC Metabolomics Market Size (2021 to 2026)

The Asia Pacific Metabolomics Market Size is valued at USD 471.68 Million in 2021 and estimated to grow at a CAGR of 17.92%, to reach USD 1075.44 Million by 2026 during the forecast period 2021-2026.

Metabolomics is the rational study of concoction forms comprising metabolites. In particular, metabolomics is the "deliberate investigation of the one of a kind synthetic fingerprints that particular cell forms desert", the study of their little molecules metabolite profiles. The metabolome signifies to the accumulation of all metabolites in natural fleshy tissue, cell, organ or life form, which are the final consequences of cell processes. The Asia Pacific Metabolomics market is developing at a very quick speed.

The increasing biotech ground-breaking work and pharmaceutical consumption are prompting persistent headways in innovation, spelling development for the worldwide metabolomics market. The developing acceptance of metabolomics in customized medicines is one of the key variables boosting the growth of the market. Then again, there are issues with respect to information handling and information examination, which can represent a test for the market. The high cost of instruments and devices can equally be an issue. Further, the necessity for very much skilled specialists and the absence of the same is limiting the improvement of the metabolomics market.

This research report on the Asia-Pacific Metabolomics Market has been segmented and sub-segmented into the following categories:

By Product: 

  • GC
  • Bioinformatics
  • Mass Spectrometry
  • HPLC
  • UPLC
  • NMRS
  • Surface-based mass analysis

By Indication: 

  • Oncology
  • Cardiology
  • Inborn Error

By Application: 

  • Nutrigenomics
  • Toxicology
  • Biomarker 
  • Drug Discovery

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

On the basis of application, the Biomarker Discovery segment had the largest share in 2016 in the global metabolomics market. Efficiency and reliability have been cited as the reason for the growth of biomarkers. However, collaboration between biotechnology and pharmaceutical companies, the personalized medical segment is expected to have the highest CAGR.

On the basis of region, China and India are likely to increase the market because of the huge population. Also, Asia Pacific is the largest growing segment.

Noteworthy companies leading the Asia Pacific Metabolomics Market analyzed in this report are Agilent Technologies, Inc. (U.S.), Human Metabolome Technologies, Inc. (Japan), Thermo Fisher Scientific, Inc. (U.S.), LECO Corporation (U.S.), Bruker Corporation (U.S.), Shimadzu Corporation (Japan), Metabolon Inc. (U.S.), Danaher Corporation (U.S.), Biocrates Life Sciences AG (Austria), and Waters Corporation (U.S.).

1.Introduction                                                  

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 Epidemology                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Product                                        

                                5.1.1 Metabolomic Instruments                               

                                                5.1.1.1Separation Techniques   

                                                                5.1.1.1.1 Gas Chromatography (GC)

                                                                5.1.1.1.2 Capillary Electrophoresis (CE)

                                                                5.1.1.1.3 High-performance Liquid Chromatography (HPLC)

                                                                5.1.1.1.4 Ultra-performance Liquid Chromatography (UPLC)

                                                5.1.1.2 Detection Tools 

                                                                5.1.1.2.1 Mass Spectrometry

                                                                5.1.1.2.2 Nuclear Magnetic Resonance Spectroscopy

                                                                5.1.1.2.3 Surface-Based Mass Analysis

                                5.1.2 Metabolomics Bioinformatics Tools and Services                   

                                                5.1.2.1 Bioinformatics Tools & Databases              

                                                5.1.2.2 Bioinformatics Services  

                                5.1.3 Y-o-Y Growth Analysis, By Product                               

                                5.1.4 Market Attractiveness Analysis, By Product                             

                                5.1.5 Market Share Analysis, By Product                               

                5.2 Indication                                    

                                5.2.1 Cancer                      

                                5.2.2 Cardiovascular Disorders                   

                                5.2.3 Inborn errors                         

                                5.2.4 Neurological Errors                              

                                5.2.5 Other Indications                 

                                5.2.4 Y-o-Y Growth Analysis, By Indication                           

                                5.2.5 Market Attractiveness Analysis, By Indication                         

                                5.2.6 Market Share Analysis, By Indication                           

                5.3 Application                                 

                                5.3.1 Nutrigenomics                       

                                5.3.2 Toxicology                               

                                5.3.3 Biomarker & Drug Discovery                            

                                5.3.4 Functional Genomics                          

                                5.3.5 Personalized Medicine                      

                                5.3.6 Other Applications

                                5.3.7 Y-o-Y Growth Analysis, By Application                         

                                5.3.8 Market Attractiveness Analysis, By Application                       

                                5.3.9  Market Share Analysis, By Application                       

6. Geographical Analysis                                                              

                6.1 Introduction                                               

                                6.1.1 Regional Trends                    

                                6.1.2 Impact Analysis                     

                                6.1.3 Y-o-Y Growth Analysis                        

                                                6.1.3.1 By Geographical Area     

                                                6.1.3.2 By Product           

                                                6.1.3.3 By Indication       

                                6.1.4 Market Attractiveness Analysis                      

                                                6.1.4.1 By Geographical Area     

                                                6.1.4.2 By Product           

                                                6.1.4.3 By Indication       

                                6.1.5 Market Share Analysis                       

                                                6.1.5.1 By Geographical Area     

                                                6.1.5.2 By Product           

                                                6.1.5.3 By Indication       

                6.2 China                                             

                6.3 India                                              

                6.4 Japan                                            

                6.5 South Korea                                               

                6.6 Australia                                      

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8.Market Leaders' Analysis                                                         

                8.1 Waters Corporation (U.S.)                                   

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

                8.2 Agilent Technologies, Inc. (U.S.)                                        

                8.3 Human Metabolome Technologies, Inc. (Japan)                                        

                8.4 Thermo Fisher Scientific, Inc. (U.S.)                                 

                8.5 LECO Corporation (U.S.)                                        

                8.6 Bruker Corporation (U.S.)                                    

                8.7 Shimadzu Corporation (Japan)                                           

                8.8 Metabolon Inc. (U.S.)                                            

                8.9 Danaher Corporation (U.S.)                                 

                8.10 Biocrates Life Sciences AG (Austria)                                              

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10.Market Outlook and Investment Opportunities                                                          

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Metabolomics Market, By Product, From 2021 to 2026 (USD Million)
  2. Asia-Pacific GC Market, By Region, From 2021 to 2026 (USD Million)
  3. Asia-Pacific Bioinformatics Market, By Region, From 2021 to 2026 (USD Million)
  4. Asia-Pacific Mass Spectroscopy Market, By Region, From 2021 to 2026 (USD Million)
  5. Asia-Pacific HPLC Market, By Region, From 2021 to 2026 (USD Million)
  6. Asia-Pacific UPLC Market, By Region, From 2021 to 2026 (USD Million)
  7. Asia-Pacific NMRS Market, By Region, From 2021 to 2026 (USD Million)
  8. Asia-Pacific Surface Based analysis Market, By Region, From 2021 to 2026 (USD Million)
  9. Asia-Pacific Metabolomics Market, By Indication, From 2021 to 2026 (USD Million)
  10. Asia-Pacific Oncology Market, By Region, From 2021 to 2026 (USD Million)
  11. Asia-Pacific Cardiology Market, By Region, From 2021 to 2026 (USD Million)
  12. Asia-Pacific Inborn Errors Market, By Region, From 2021 to 2026 (USD Million)
  13. Asia-Pacific Metabolomics Market, By Application, From 2021 to 2026 (USD Million)
  14. Asia-Pacific Nutrigenomics Market, By Region, From 2021 to 2026 (USD Million)
  15. Asia-Pacific Toxicology Market, By Region, From 2021 to 2026 (USD Million)
  16. Asia-Pacific Biomarker & Drug Discovery Market, By Region, From 2021 to 2026 (USD Million)
  17. Japan Metabolomics Market, By Product, From 2021 to 2026 (USD Million)
  18. Japan Metabolomics Market, By Indication, From 2021 to 2026 (USD Million)
  19. Japan Metabolomics Market, By Application, From 2021 to 2026 (USD Million)
  20. China Metabolomics Market, By Product, From 2021 to 2026 (USD Million)
  21. China Metabolomics Market, By Indication, From 2021 to 2026 (USD Million)
  22. China Metabolomics Market, By Application, From 2021 to 2026 (USD Million)
  23. India Metabolomics Market, By Product, From 2021 to 2026 (USD Million)
  24. India Metabolomics Market, By Indication, From 2021 to 2026 (USD Million)
  25. India Metabolomics Market, By Application, From 2021 to 2026 (USD Million)
  26. Australia Metabolomics Market, By Product, From 2021 to 2026 (USD Million)
  27. Australia Metabolomics Market, By Indication, From 2021 to 2026 (USD Million)
  28. Australia Metabolomics Market, By Application, From 2021 to 2026 (USD Million)
  29. South Korea Metabolomics Market, By Product, From 2021 to 2026 (USD Million)
  30. South Korea Metabolomics Market, By Indication, From 2021 to 2026 (USD Million)
  31. South Korea Metabolomics Market, By Application, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample